Holen Sie sich die Stockscreener-App
10.69
1.75%
-0.19
Handel nachbörslich:
10.75
0.06
+0.56%
Schlusskurs vom Vortag:
$10.88
Offen:
$10.95
24-Stunden-Volumen:
4.26M
Relative Volume:
2.44
Marktkapitalisierung:
$1.06B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.84M
KGV:
-22.74
EPS:
-0.47
Netto-Cashflow:
$-44.23M
1W Leistung:
-16.87%
1M Leistung:
-38.49%
6M Leistung:
+1.71%
1J Leistung:
-10.39%
1-Tages-Spanne:
$10.33
$11.03
1-Wochen-Bereich:
$10.33
$12.70
52-Wochen-Spanne:
$10.01
$18.90
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
Firmenname
Ars Pharmaceuticals Inc
Sektor
Branche
Telefon
858-771-9307
Adresse
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
Vergleichen Sie SPRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRY
Ars Pharmaceuticals Inc
|
10.69 | 1.10B | 0 | -44.84M | -44.23M | -0.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-08-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-12 | Bestätigt | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | Raymond James | Outperform |
| 2024-03-05 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-02-20 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-09-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Wedbush | Outperform |
| 2023-01-03 | Eingeleitet | William Blair | Outperform |
| 2022-12-13 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Ars Pharmaceuticals Inc Aktie (SPRY) Neueste Nachrichten
Can ARS Pharmaceuticals Inc. be the next market leaderJuly 2025 Volume & Momentum Based Trading Ideas - khodrobank.com
What are ARS Pharmaceuticals Inc.’s growth leversJuly 2025 Recap & Trade Opportunity Analysis Reports - khodrobank.com
Intraday pattern recognizer results for ARS Pharmaceuticals Inc.CEO Change & Precise Entry and Exit Recommendations - Newser
How volatile is ARS Pharmaceuticals Inc. stockJuly 2025 Rallies & Risk Controlled Stock Alerts - khodrobank.com
Real time pattern detection on ARS Pharmaceuticals Inc. stockJuly 2025 Price Swings & High Accuracy Buy Signal Tips - Newser
Chart overlay techniques for tracking ARS Pharmaceuticals Inc.Weekly Investment Report & Reliable Entry Point Alerts - Newser
Can ARS Pharmaceuticals Inc. rally from current levelsMarket Activity Report & Low Risk Growth Stock Ideas - Newser
What recovery options are there for ARS Pharmaceuticals Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Risk vs reward if holding onto ARS Pharmaceuticals Inc.2025 Trading Recap & Intraday High Probability Alerts - Newser
ARS Pharmaceuticals Inc. recovery potential after sell off2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
When is the best time to exit ARS Pharmaceuticals Inc.July 2025 Update & Fast Exit Strategy with Risk Control - Newser
Using economic indicators to assess ARS Pharmaceuticals Inc. potentialJuly 2025 Outlook & Fast Entry High Yield Tips - Newser
What machine learning models say about ARS Pharmaceuticals Inc.Portfolio Gains Report & Safe Entry Zone Identification - Newser
Will ARS Pharmaceuticals Inc. benefit from seasonalityMarket Performance Report & Low Drawdown Momentum Ideas - khodrobank.com
What drives ARS Pharmaceuticals Inc.’s stock priceJuly 2025 News Drivers & Fast Gain Stock Tips - khodrobank.com
Insider Sell: Is ARS Pharmaceuticals Inc. stock a hidden gemQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - khodrobank.com
Can ARS Pharmaceuticals Inc. deliver consistent dividendsJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - khodrobank.com
Is ARS Pharmaceuticals Inc. stock trending bullishJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - khodrobank.com
What moving averages say about ARS Pharmaceuticals Inc.Quarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Is ARS Pharmaceuticals Inc. stock a falling knife or bargain buy2025 Price Momentum & Free Expert Verified Stock Movement Alerts - khodrobank.com
How does ARS Pharmaceuticals Inc. compare to its peersBull Run & Expert Approved Momentum Trade Ideas - khodrobank.com
Custom watchlist performance reports with ARS Pharmaceuticals Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - Newser
Using flow based indicators on ARS Pharmaceuticals Inc.2025 Momentum Check & Expert Verified Movement Alerts - Newser
What’s the outlook for ARS Pharmaceuticals Inc.’s sectorWeekly Stock Recap & Intraday High Probability Setup Alerts - khodrobank.com
Using data models to predict ARS Pharmaceuticals Inc. stock movementJuly 2025 Market Mood & Reliable Entry Point Alerts - Newser
Comparing ARS Pharmaceuticals Inc. in custom built stock radars2025 Institutional Moves & Long Hold Capital Preservation Plans - Newser
Published on: 2025-09-01 14:50:55 - Newser
Does ARS Pharmaceuticals Inc. have strong fundamentalsJobs Report & Advanced Technical Analysis Signals - خودرو بانک
ARS Pharmaceuticals Inc. At Decision Level — Rebound or Resistance2025 Performance Recap & Long-Term Growth Plans - beatles.ru
Quantitative breakdown of ARS Pharmaceuticals Inc. recent moveJuly 2025 Action & Pattern Based Trade Signal System - Newser
Real time social sentiment graph for ARS Pharmaceuticals Inc.Insider Selling & Expert-Curated Trade Recommendations - Newser
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion - TipRanks
Is ARS Pharmaceuticals Inc. forming a bottoming base2025 Market Overview & Fast Gain Swing Alerts - Newser
How to monitor ARS Pharmaceuticals Inc. with trend dashboardsQuarterly Profit Report & Free Technical Confirmation Trade Alerts - Newser
Analyzing ARS Pharmaceuticals Inc. with multi timeframe charts2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
Analyzing net buyer seller activity in ARS Pharmaceuticals Inc.2025 Key Highlights & Risk Controlled Stock Alerts - Newser
How to interpret RSI for ARS Pharmaceuticals Inc. stockWeekly Risk Report & AI Powered Market Entry Strategies - Newser
What MACD and RSI say about ARS Pharmaceuticals Inc.July 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Ranking ARS Pharmaceuticals Inc. among high performing stocks via toolsQuarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Technical analysis overview for ARS Pharmaceuticals Inc. stock - Newser
ARS Pharma drops 9% as Lupin files application for generic neffy - MSN
Machine Learning Models Forecast ARS Pharmaceuticals Inc. Uptick getLinesFromResByArray error: size == 0 - kangso.co.kr
What machine learning models say about ARS Pharmaceuticals Inc2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
How hedge fund analytics apply to ARS Pharmaceuticals Inc. stockSwing Trade & Proven Capital Preservation Tips - Newser
How high can ARS Pharmaceuticals Inc. stock goSell Signal & Daily Volume Surge Trade Alerts - Newser
Finanzdaten der Ars Pharmaceuticals Inc-Aktie (SPRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ars Pharmaceuticals Inc-Aktie (SPRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Scott Kathleen D. | Chief Financial Officer |
Aug 21 '25 |
Option Exercise |
1.50 |
12,500 |
18,750 |
22,542 |
| Scott Kathleen D. | Chief Financial Officer |
Aug 21 '25 |
Sale |
15.00 |
12,500 |
187,500 |
10,042 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER |
Aug 20 '25 |
Sale |
14.09 |
37,656 |
530,626 |
1,247,447 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER |
Aug 19 '25 |
Sale |
14.03 |
12,344 |
173,130 |
1,285,103 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):